EP Patent

EP2495251A1 — Hydrochloride salts of a glycopeptide phosphonate derivative

Assigned to Theravance Biopharma Antibiotics IP LLC · Expires 2012-09-05 · 14y expired

What this patent protects

Disclosed are hydrochloride salts of telavancin having a chloride ion content of from 3.7 wt. % to 4.4 wt. %. The disclosed salts have improved stability during storage at ambient temperatures compared to other hydrochloride salts.

USPTO Abstract

Disclosed are hydrochloride salts of telavancin having a chloride ion content of from 3.7 wt. % to 4.4 wt. %. The disclosed salts have improved stability during storage at ambient temperatures compared to other hydrochloride salts.

Drugs covered by this patent

Patent Metadata

Patent number
EP2495251A1
Jurisdiction
EP
Classification
—
Expires
2012-09-05
Drug substance claim
No
Drug product claim
No
Assignee
Theravance Biopharma Antibiotics IP LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.